We have previously localized the T1D association in the region containing the IL2RA gene to three independent SNP groups (haplotypes) found in noncoding regions spanning 18 kb directly 5¢ of IL2RA to 25 kb into intron 1 of the gene [2] [3] [4] . The most significantly associated T1D SNPs that define the four common disease-associated IL2RA haplotypes are rs12722495 (ref. Although none of these SNPs are located within known regulatory regions, we hypothesized that the causative variants may alter CD25 protein expression on the surface of immune cells. The existence of multiple IL2RA haplotypes, as well as a distinct pattern of haplotype association with multiple sclerosis 4 , predicts a complex, haplotype-directed CD25 expression pattern. CD25 is expressed constitutively on numerous immune cell types 5 , such as CD4 + FOXP3 + regulatory T cells (Tregs) and CD4 + memory T cells 6 (Fig. 2) , and is upregulated upon activation in many cells, including certain innate immune cell subsets 7 . We therefore investigated haplotype-dependent, cell subset-specific variation in surface CD25 levels on peripheral blood CD4 + memory, naive and regulatory T cells (as well as stimulated monocyte subsets) by singlecell polychromatic flow cytometry ( Table 1) . This allows multiple cell types to be studied simultaneously even if they represent only a small peripheral blood subpopulation, as with Tregs 6 .
To increase the likelihood of identifying gene-phenotype correlations, study participants were specifically selected on the basis of IL2RA haplotype. We used the Cambridge BioResource, a collection of B5,000 volunteers living in the Cambridge region who donated blood and saliva samples for research purposes and can be invited to participate in specific research studies based on genotype. The four common IL2RA haplotypes comprise (i) susceptibility alleles at all three SNPs; (ii) a protective rs12722495 allele, which predominantly co-occurs with a protective rs2104286 allele; (iii) a protective rs11594656 allele; and (iv) a protective rs2104286 allele ( Fig. 1a ; Supplementary Table 1d) . We aimed to obtain B50 individuals homozygous or heterozygous for each of the three protective haplotypes and 50 individuals homozygous for the susceptible haplotype. Individuals heterozygous for two different protective haplotypes were excluded, and thus all heterozygous individuals studied had one protective and one susceptible haplotype. Of the 2,212 individuals who met our recruitment criteria, we contacted B100 from each haplotype group (Supplementary Table 2) , and 179 individuals were analyzed in total (Fig. 1b) . Notably, using this haplotypespecific approach to select samples, we succeeded in analyzing 16 individuals homozygous for the protective rs12722495 allele, even though the frequency of such individuals in the Cambridge BioResource is only 1%. All donors selected were of self-reported non-autoimmune disease status. We assessed healthy donors because genetic effects on a phenotype could be confounded by the presence of disease 8 , particularly as CD25 is known to be upregulated under inflammatory conditions 5 .
We found that individuals with one or two protective rs12722495 alleles show 27% higher mean CD25 levels on their CD4 + memory T cells compared to fully susceptible individuals or to donors with protective rs11594656 or rs2104286 alleles (P ¼ 4.30 Â 10 À9 ; Fig. 3a) . Furthermore, there is a gene dosage effect at rs12722495 (P ¼ 1.16 Â 10 À10 ; Fig. 3b ; see Fig. 2 for representative profiles), with heterozygous and homozygous protective individuals having 22% and 33% higher mean CD25 levels, respectively, compared to homozygous susceptible individuals. This gene dosage effect is consistent with the T1D allelic risk following a conventional multiplicative model whereby the risk with two doses of an allele is the square of the risk with one allele. No dosage effect was found for rs11594656 or rs2104286
( Supplementary Fig. 1a-c) , and this phenotype was not associated with donor age or sex ( Table 1) . The genetically variable surface CD25 levels on CD4 + memory T cells likely reflect haplotype-dependent transcriptional differences. We found that in total CD4 + T cells and Figure 1 The four common IL2RA (CD25) haplotypes and summary of the subject statistics by haplotype group. (a) The three independent T1D-associated SNP groups are located in the noncoding, 5¢ and intron 1 regions of the IL2RA gene on chromosome 10. The number of SNPs per associated group is 8, 3 and 2, as previously described, with each SNP being represented by a vertical bar [2] [3] [4] . Gray bars represent susceptibility alleles at these SNPs; the red, blue and orange bars represent protective alleles for each respective SNP group. The most associated SNPs in each group are rs12722495 (A4G), rs11594656 (T4A) and rs2104286 (A4G). The major alleles at all three SNPs are T1D susceptible and the minor alleles are protective. Using the genotypes at these SNPs, four common haplotypes can be defined: 'Susceptible', 'rs12722495', 'rs11594656' and 'rs2104286'. The frequency of these haplotypes in B9,000 healthy control individuals is shown, and the T1D association and odds ratios (OR) of the protective haplotypes were calculated relative to the 'Susceptible' haplotype using B7,000 case and B9,000 control samples (Supplementary Table 1 CD4 + memory T cells from donors who were heterozygous for both the protective rs12722495 and the fully susceptible haplotypes, there were B30% more pre-mRNA transcripts from the protective haplotype, as determined by cloning-based ASE assays 9 designed for SNPs in intron 1 of IL2RA (Supplementary Table 3 , Supplementary Fig. 2 ). Notably, the surface CD25 levels of CD4 + memory T cells were highly consistent over time (r 2 ¼ 0.997; Supplementary Fig. 1d ), as demonstrated in 15 donors recalled 3-7 months after their initial donation. This repeatability was compromised, however, when 14 peripheral blood mononuclear cell (PBMC) samples were analyzed 9-10 months after cryopreservation for CD25 levels on the CD4 + memory T cells, as these levels were 28-62% lower than those found on the CD4 + memory T cells analyzed in fresh whole blood on the day the PBMCs were isolated and frozen ( Supplementary Fig. 1e ). The IL2RA genotype was estimated to account for 18% of CD25 variation in fresh peripheral blood CD4 + memory T cells. Inter-individual variation in donors with homozygous protective rs12722495 alleles was lower than in homozygous susceptible donors (F-test P ¼ 0.003). Given the phenotype repeatability, this indicates that other IL2RA SNPs, variants at other genes, or environmental factors alter CD25 expression on CD4 + memory T cells, but that these effects are only observable in individuals with rs12722495 susceptibility alleles. We note that no correlation was observed between mean surface CD25 levels on FOXP3 + T cells and the IL2RA haplotype ( Supplementary Fig. 3a-d) .
In contrast to the rs12722495 genotypic correlation for increased CD25 on CD4 + memory cells, the percentage of CD4 + naive cells that are CD25 + was lower in individuals with protective alleles at rs2104286 (P ¼ 4.25 Â 10 À6 ; Fig. 3c,d ; Supplementary Fig. 3e-h ), regardless of whether these alleles co-occur on the same haplotype as protective rs12722495 alleles. This phenotype also had good repeatability (r 2 ¼ 0.669). We also obtained evidence for a genotype-phenotype correlation for CD25 upregulation on a stimulated monocyte subset ( Table 1 ; Supplementary Fig. 4 ), which was analogous to that for CD4 + naive cells. (c) Eight pairs of previously immunophenotyped donors were recalled such that in each pair, one donor was homozygous for the protective rs12722495 haplotype and one donor was homozygous for the fully susceptible haplotype (and had CD4 + memory T cells with CD25 levels o800 MEF). Susceptible donors were selected to have low CD25 levels on their CD4 + memory cells in order to test the hypothesis that differential CD25 expression results in differential IL-2 production. A higher proportion of the CD69 + CD4 + memory T cells from protective donors secrete IL-2 compared to fully susceptible donors (P ¼ 5.74 Â 10 À4 ). The average difference in CD25 levels of the unstimulated CD4 + memory T cells between the protective and susceptible donors (23.2%) corresponds to the average difference in IL-2 secretion observed for these donors (22.5%). (d) A genotypic correlation was not observed for the proportion of CD69 + CD4 + naive T cells secreting IL-2 (P ¼ 0.318).
Considering our results collectively ( Table 1) , relative to the susceptible haplotype, the protective rs12722495 haplotype (OR ¼ 0.57; G, protective, minor allele at rs12722495), which is also protective at rs2104286 (G allele), is correlated with three phenotypic changes (in CD4 + memory and naive T cells and in stimulated CD14 + CD16 + monocytes). In comparison, the protective rs2104286 haplotype (OR ¼ 0.88; G, protective, minor allele at rs2104286) is correlated with only two phenotypic changes (in CD4 + naive T cells and stimulated CD14 + CD16 + monocytes). This may, in part, explain their differing strengths of association to T1D. We propose that the CD4 + memory T-cell phenotype is critical for protection from T1D but not from multiple sclerosis, for which rs2104286 (OR ¼ 0.85; G, protective, minor allele at rs2104286) is the most strongly associated SNP 4,10 , whereas the naive T-cell and stimulated CD14 + CD16 + monocyte phenotypes are implicated in both diseases.
The IL2RA haplotype-specific CD25 expression patterns in CD4 + naive and memory T cells are consistent with these cells being distinct cell types, as determined by gene expression changes that occur with T-cell maturation and differentiation 11 , including those mediated by chromosome remodeling and altered transcription and splicing factors. According to the quantal theory of immunity, T-cell responses depend on cells receiving a critical number of T cell receptor (TCR)-and IL2R-mediated stimuli 12 . For CD4 + -naive T cells, the protective rs2104286 genotype reduces the probability of this cell type expressing CD25, thereby reducing the likelihood of activation. Indeed, we found that this genotypic effect persisted upon T cell activation, such that a lower proportion of CD69 + CD4 + naive T cells upregulated CD25 in donors carrying the protective rs2104286 allele compared to fully susceptible donors ( Supplementary Fig. 5 ). In contrast, because individuals with protective rs12722495 alleles have higher CD25 levels on their CD4 + memory cells, these cells are likely more responsive to IL-2 and to TCR-mediated activation. In mice it has been hypothesized that these nonregulatory CD4 + CD25 + T cells are the primary source in vivo of the IL-2 required for FOXP3 + Treg homeostasis and competitive fitness [13] [14] [15] . This is consistent with the correlation between an B50% reduction in IL-2 abundance and reduced Treg function in mice carrying two T1D susceptibility alleles at Idd3 (refs. 16, 17) . By analogy, it is possible that when human nonregulatory CD4 + memory T cells express higher levels of CD25 due to the protective rs12722495 haplotype, homeostatic IL-2 production is increased; this would be consistent with observed defects in IL-2 production shown by individuals with T1D 18, 19 . In support of this hypothesis, we have found that upon stimulation, a higher percentage of CD69 + CD4 + memory T cells from protective rs12722495 homozygous donors secrete IL-2 compared with those from homozygous susceptible donors (P ¼ 5.74 Â 10 À4 ; Fig. 4 ). An alternative, or additional, mechanism to reinforce self-tolerance that would be improved with higher CD25 levels on activated, anti-self effector T cells is activation-induced cell death 20, 21 . Modest increases in IL-2 production enable mice to more efficiently establish transplant tolerance, presumably via this mechanism 22 .
This study represents the first description of gene-phenotype correlations between protein levels on specific subsets of primary human immune cell types and autoimmune disease-associated variants. We provide evidence for three immune cell type-specific quantitative trait effects on protein expression associated with two protective IL2RA haplotypes, providing further support for IL2RA as a T1D-causative gene at the 10p15.1 locus. We also delineate important parameters for the design and practical implementation of gene-phenotype correlation studies. The establishment of a panel of thousands of healthy donors recallable by genotype and resident near the study location was critical to the success of our approach, as was the analysis of fresh rather than frozen primary immune cells. Given the necessity for advances in the field of human immunology 23, 24 , our findings illustrate that although the human population is genetically diverse and individuals are subjected to immune challenges, gene-phenotype correlations can indeed be dissected. Our results will also direct further studies to examine the functional consequences of IL2RA genetic variation in vitro and in animal models of autoimmune disease.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturegenetics/.
Note: Supplementary information is available on the Nature Genetics website.
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ONLINE METHODS
We aimed to obtain samples from B200 donors enriched for less common IL2RA genotypes and including at least one donor from each of our four haplotype groups on each sample donation day to minimize any day-ofcollection effects. The immunophenotyping was conducted in a genotypeblinded fashion. We designed our study to be able to detect an effect size as small as 50% of the genotype-related difference in CTLA-4 expression observed in previous work 25 . Given these prior estimates a power study shows that a random sampling of the population would provide 10% power to detect a gene-phenotype correlation at P ¼ 10 À5 . With the same total number of donors and the allele distribution resulting from our genotype-specific sampling, we have obtained 87% power at the same significance level.
Genotyping. SNPs were genotyped using Custom TaqMan SNP Genotyping Assays or Taqman (Applied Biosystems) in accordance with the manufacturers' protocols. All genotyping data were double scored by a second operator to minimize error.
Antibodies and whole blood immunostaining. The anti-human monoclonal used for T-cell surface immunostaining were allophycocyanin (APC)-conjugated anti-CD25 (clones M-A251 and 2A3; BD Biosciences), Alexa Fluor 700-conjugated anti-CD4, Alexa Fluor 488-conjugated anti-CD127 and Pacific Blue-conjugated anti-CD45RA (BioLegend). The isotype control antibodies used were APC-conjugated mouse IgG1 (BD Biosciences) and Alexa Fluor 488-conjugated mouse IgG1 (BioLegend). To minimize potential variation due to antibody batch differences, all antibodies were obtained prior to the start of the experiment and all vials of antibody derived from the same clone and labeled with the same fluorochrome were pooled prior to usage. To better visualize lower-level surface CD25 expression, we increased CD25 detection sensitivity by simultaneously using two anti-CD25 monoclonals, labeled with the same fluorochrome (from clones 2A3 and M-A251, BD Biosciences), that do not cross-compete and that recognize distinct epitopes on the CD25 molecule 26, 27 .
Samples were stained within 5 h after venesection. After blocking, samples were stained for 40 min and then lysed with freshly prepared 1Â BD FACS Lysing Solution (BD Biosciences). After erythrocyte lysis, samples were incubated at 4 1C and were washed with BD CellWASH (BD Biosciences). The samples were fixed with freshly prepared 1Â BD CellFIX (BD Biosciences). The samples were stored at 4 1C until analysis by flow cytometry or intracellular staining. For intracellular staining, the PE (phycoerythrin)-anti-human FOXP3 Staining Set from eBioscience was used, according to the manufacturer's instructions.
Flow cytometry and data analysis. Immunostained samples were analyzed using a BD LSRII Flow Cytometer with BD FACSDiVa Software (BD Biosciences). The flow cytometry data obtained were analyzed using FlowJo (Tree Star, Inc.). Each day that donor samples were evaluated, FluoroSpheres were also analyzed (Blank Beads and Calibration Beads, Dakocytomation). The Calibration Beads contain a mixture of bead populations of different fluorescence intensities that have been assigned specific 'molecules of equivalent fluorochrome' (MEF) values; thus, they allow the transformation of mean or median fluorescence intensity (MFI) into mean or median MEF, which is a quantity proportional to the average number of molecules on a cell. This transformation is linear, MEF ¼ a Â MFI, where the slope a is a measure of the number of molecules equivalent to one unit of fluorescence.
Statistical analysis of flow cytometry data. All statistical tests were performed using the R statistical software package. Regression analysis and analysis of variance (ANOVA) were used to test for correlations between genotypes and phenotypes, controlling for age and sex. Genotype-phenotype correlations were analyzed assuming a linear genotype-phenotype relationship (1-d.f. F-test) . A conservative significance threshold was estimated (P ¼ 5.56 Â 10 À4 ) using a Bonferroni correction for multiple testing (using a P value of 0.01 and assuming six potential CD25-related phenotypes and three IL2RA SNPs, giving a total of 18 independent hypotheses). The percentage of IL2RA genotype accounting for the variation in CD4 + memory T-cell CD25 levels was estimated by least-squares regression analysis. One donor was excluded from the CD4 + T-cell data and another was excluded from the monocyte data on the basis that the CD25 levels of these individuals differed from the mean of the rest of the donors by at least 5 s.d., and these individuals were thus considered to be outliers.
PBMC isolation, cryopreservation and thawing. PBMC isolation, cryopreservation and thawing were performed as previously described 28 . PBMC isolation was carried out using Lymphoprep (Fresenius Kabi Norge AS for Axis-Shield PoC AS). PBMCs were cryopreserved in heat-inactivated, filtered human AB serum (Sigma-Aldrich) + 10% DMSO (Hybri-MAX, SigmaAldrich) at a final concentration of 10 Â 10 6 ml À1 and were stored in liquid nitrogen. Cryovials were thawed in a 37 1C water bath. PBMCs were washed by adding 5 ml of room-temperature (20-25 1C), heat-inactivated, filtered human AB serum and then 5 ml of RPMI-1640 + GlutaMAX I + 25 mM HEPES (Gibco, Invitrogen) per 10 Â 10 6 cells, in a drop-wise fashion.
Cloning-based allele-specific expression assay. PBMCs were isolated from three donors heterozygous for the protective rs12722495 and fully susceptible haplotypes. CD4 + T cells were obtained from PBMCs using the Dynabeads Untouched Human CD4 T Cells kit (Dynal, Invitrogen). CD4 + memory T-cell enrichment was carried out using the Dynabeads Untouched Human CD4 T Cells kit with the inclusion of unconjugated anti-CD45RA and anti-HLA-DR (BD Biosciences), to remove CD4 + naive T cells and the majority of CD4 + CD127 int-low CD25 hi regulatory T cells along with non-CD4 + T cells. Cell purity was estimated by flow cytometry.
Genomic DNA was obtained from PBMCs by chloroform extraction. Total RNA was extracted from the negatively selected cells using TRIzol Reagent (Invitrogen) and further purified using the RNeasy Mini kit (Qiagen), according to the manufacturers' instructions. RNA was left either unfragmented or fragmented 29 to provide better coverage throughout the gene 30 . Complementary DNA synthesis was then carried out using Superscript III RT kit and oligo(dT) or random-hexamer primers (Invitrogen). After cDNA synthesis using fragmented RNA, 150-350-bp-long cDNA molecules were gel-purified using QIAquick Gel Extraction Kit (Qiagen). Primers flanking the rs12722495 and rs2104286 SNPs were used to amplify the cDNA and genomic DNA by PCR. PCR products were gel-purified and ligated into pCR4-TOPO Vector and transformed chemically into One Shot TOP10 competent Escherichia coli cells (Invitrogen).
Bacterial colonies were picked and PCR amplification was performed using an AmpliTaq Gold protocol (ABI). PCR products were screened by TaqMan genotyping (ABI). Alleles were scored on SDS v2.1 software (ABI) manually and counted. Statistical analysis was performed using a 2 Â 2 contingency table to calculate one-tailed P values for T1D-associated SNPs, whereas a two-tailed P value was used for rs12244380, as the phase for the alleles of this SNP relative to the T1D-associated SNPs could not be determined. Assuming a 30% allelic imbalance between the protective rs12722495 and fully susceptible haplotypes, we calculated that 350 colonies needed to be selected to provide 80% power to
